US regulatory status: approved. Molecular target: Cyclooxygenase.
- Target
- Cyclooxygenase
- Mechanism
- Cyclooxygenase inhibitor
pharma · Mild/non-serious osteoarthritis (OA) of the knee.
Haleon - Gebro
HALEON AUSTRALIA PTY LTD
Haleon - Gebro drug portfolio — 9 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Fieberbrunn, AU HQ
179 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Fieberbrunn, AU
- Employees
- 179
- Programs
- 3
- Drugs
- 9
- Patents
- 0
Haleon - Gebro pipeline
Portfolio lens on 9 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Haleon - Gebro drug portfolio — 9 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Molecular target: Cyclooxygenase.
- Target
- Cyclooxygenase
- Mechanism
- Cyclooxygenase inhibitor
-
US regulatory status: approved. Molecular target: Muscarinic acetylcholine receptor M1.
- Target
- Muscarinic acetylcholine receptor M1
- Mechanism
- Muscarinic acetylcholine receptor M1 antagonist
-
US regulatory status: approved. Molecular target: Neuronal acetylcholine receptor; alpha4/beta2.
- Target
- Neuronal acetylcholine receptor; alpha4/beta2
- Mechanism
- Neuronal acetylcholine receptor; alpha4/beta2 agonist
-
Development asset linked to Haleon - Gebro in public FDA and regional records. Molecular target: Fatty-acid amide hydrolase 1.
- Target
- Fatty-acid amide hydrolase 1
- Mechanism
- Anandamide amidohydrolase inhibitor
-
US regulatory status: approved. Molecular target: Sodium-dependent noradrenaline transporter.
- Target
- Sodium-dependent noradrenaline transporter
- Mechanism
- Norepinephrine transporter releasing agent
-
Development asset linked to Haleon - Gebro in public FDA and regional records.
-
Development asset linked to Haleon - Gebro in public FDA and regional records.
-
Development asset linked to Haleon - Gebro in public FDA and regional records.